Metagenomi, Inc. - Common Stock (NQ: MGX )
3.220
+0.160
(+5.23%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Metagenomi, Inc. - Common Stock
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Unveiling 4 Analyst Insights On Metagenomi
August 21, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/08/19/Insights-From-Analysts.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://ml.globenewswire.com/media/bbc60475-ea30-4341-9029-3179ae7de511/small/mg-logo-lockup-b-spruce-png.png)
From Metagenomi, Inc.
Via GlobeNewswire
![](https://mms.businesswire.com/media/20240811568771/en/779279/5/Screen_Shot_2020-03-10_at_10.22.21_AM.jpg)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://mms.businesswire.com/media/20240802082945/en/779279/5/Screen_Shot_2020-03-10_at_10.22.21_AM.jpg)
![](https://mms.businesswire.com/media/20240730632895/en/827144/22/Schall-Firm-Logo-640x360.jpg)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://mms.businesswire.com/media/20240718203887/en/478343/5/GPM_Logo_Colo.jpg)
![](https://mms.businesswire.com/media/20240717363334/en/774509/22/new_KM_logo.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20240716726418/en/765953/22/Close_Up_Logo_HD_Blue.jpg)
![](https://ml.globenewswire.com/media/bbc60475-ea30-4341-9029-3179ae7de511/small/mg-logo-lockup-b-spruce-png.png)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://ml.globenewswire.com/media/bbc60475-ea30-4341-9029-3179ae7de511/small/mg-logo-lockup-b-spruce-png.png)
![](https://cdn.benzinga.com/files/images/story/2024/05/02/Moderna-COVID-19-vaccine-2021-G.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2020/03/gene_editing_c_1600.jpg)
![](https://ml.globenewswire.com/media/bbc60475-ea30-4341-9029-3179ae7de511/small/mg-logo-lockup-b-spruce-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://ml.globenewswire.com/media/bbc60475-ea30-4341-9029-3179ae7de511/small/mg-logo-lockup-b-spruce-png.png)
Metagenomi to Present at Upcoming Scientific Meetings
April 08, 2024
From Metagenomi, Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/bbc60475-ea30-4341-9029-3179ae7de511/small/mg-logo-lockup-b-spruce-png.png)
From Metagenomi, Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/bbc60475-ea30-4341-9029-3179ae7de511/small/mg-logo-lockup-b-spruce-png.png)
Metagenomi to Participate in the 44th Annual Cowen Healthcare Conference
February 29, 2024
Via GlobeNewswire
![](https://g.foolcdn.com/editorial/images/765221/group-of-scientists-with-microscopes-lab-testing.jpg)
![](https://ml.globenewswire.com/media/bbc60475-ea30-4341-9029-3179ae7de511/small/mg-logo-lockup-b-spruce-png.png)
Metagenomi Announces Closing of Initial Public Offering
February 13, 2024
Via GlobeNewswire
![](https://talkmarkets.com/user_content/ckimages/orig_46090766321_9ae7b253d1_c.jpg)
Gilead-Backed Kyverna Overshoots Raised IPO Expectations
February 11, 2024
Via Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.